Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Danysz

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Expert Opinion on Investigational Drugs|June 27, 2001
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspectsW Danysz
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Metaphit fails to antagonize PCP-induced passive avoidance deficitW Danysz
Idrugs : the Investigational Drugs Journal|August 30, 2005
CX-516 (Cortex Pharmaceuticals Inc)W Danysz
Neuropharmacology|June 24, 2006
Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin testN Sevostianova, W Danysz
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantineP Popik, W Danysz
Pharmacology, Biochemistry, and Behavior|January 1, 1997
Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesionsW Zajaczkowski, W Danysz
Amino Acids|November 5, 2013
Glutamate, learning and dementia-selection of evidenceW Danysz, T Archer
Journal of Neural Transmission (Vienna, Austria : 1996)|January 26, 2002
Chronic cerebral hypoperfusion in the rat enhances age-related deficits in spatial memoryM Sopala, W Danysz
Behavioural Pharmacology|August 1, 1995
Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidanceM. Misztal, W. Danysz
Psychiatria Polska|September 1, 1992
[Sigma receptors: the key to therapeutic action or the side-effects of neuroleptics?]W Danysz, W Kostowski
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|June 27, 2001
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspectsW Danysz
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Metaphit fails to antagonize PCP-induced passive avoidance deficitW Danysz
Idrugs : the Investigational Drugs Journal|August 30, 2005
CX-516 (Cortex Pharmaceuticals Inc)W Danysz
Neuropharmacology|June 24, 2006
Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin testN Sevostianova, W Danysz
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantineP Popik, W Danysz
Pharmacology, Biochemistry, and Behavior|January 1, 1997
Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesionsW Zajaczkowski, W Danysz
Amino Acids|November 5, 2013
Glutamate, learning and dementia-selection of evidenceW Danysz, T Archer
Journal of Neural Transmission (Vienna, Austria : 1996)|January 26, 2002
Chronic cerebral hypoperfusion in the rat enhances age-related deficits in spatial memoryM Sopala, W Danysz
Behavioural Pharmacology|August 1, 1995
Comparison of glutamate antagonists in continuous multiple-trial and single-trial dark avoidanceM. Misztal, W. Danysz
Psychiatria Polska|September 1, 1992
[Sigma receptors: the key to therapeutic action or the side-effects of neuroleptics?]W Danysz, W Kostowski
Pageof 15